We are live on ! Find out more
FEED

ENvue Medical Inc

6 hedge funds and large institutions have $42.5K invested in ENvue Medical Inc in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

348% more capital invested

Capital invested by funds: $9.5K → $42.5K (+$33K)

1.48% more ownership

Funds ownership: 0.21%1.69% (+1.5%)

0% more funds holding

Funds holding: 66 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
6
Holders Change
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
3
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$38.2K +$77.8K +16,516 New
TRCT
2
Tower Research Capital (TRC)
New York
$4.17K +$5.55K +1,178 +188%
UBS Group
3
UBS Group
Switzerland
$139 +$118 +25 +71%
SS
4
SBI Securities
Japan
$35
Bank of America
5
Bank of America
North Carolina
$18 +$9 +2 +33%
Citigroup
6
Citigroup
New York
$2
Morgan Stanley
7
Morgan Stanley
New York
-$5.64K -1,000 Closed

FEED Hedge Fund Activity: Q4 2025 in Review

6 of the 8,232 institutional investors tracked by Wall St. Rank reported a position in ENvue Medical Inc (FEED) for Q4 2025, worth a combined $42.5K — up 348% from $9.5K a quarter earlier.

Fund positioning in FEED was balanced in Q4 2025: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $77.8K. The largest seller was Morgan Stanley, exiting entirely with an estimated $5.64K sold.

  • 6 institutional investors held ENvue Medical Inc (FEED) as of Q4 2025, unchanged from Q3 2025.
  • Funds reported $42.5K of ENvue Medical Inc stock for Q4 2025, up 348% quarter-over-quarter.
  • 1 fund opened new ENvue Medical Inc positions in Q4 2025 and 1 closed out, a net change of 0 holders.
  • The largest ENvue Medical Inc buyer in Q4 2025 was Citadel Advisors, an estimated $77.8K added.
  • The largest ENvue Medical Inc seller in Q4 2025 was Morgan Stanley, an estimated $5.64K sold.

Based on aggregated 13F filings for Q4 2025.